Across TCGA pan-cancer cohorts, MIR320D2 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR320D2 data layer compared with 4 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR320D2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR320D2 expression acts as an unfavorable survival marker.

COAD and STAD are the cancer types where MIR320D2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.103	0.801	<.001	24	view →
STAD	DFS	Median	All	0.122	0.657	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR320D2 tumor-vs-normal RNA expression · all MIR320D2 data types